These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 32015881)

  • 1. Molecular diversity of extended-spectrum β-lactamases and carbapenemases, and antimicrobial resistance.
    Sawa T; Kooguchi K; Moriyama K
    J Intensive Care; 2020; 8():13. PubMed ID: 32015881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [MULTIRESISTANT BACTERIA].
    Bedenić B; Sardelić S; Ladavac M
    Acta Med Croatica; 2015 Sep; 69(3):211-6. PubMed ID: 29077379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
    Zhanel GG; Golden AR; Zelenitsky S; Wiebe K; Lawrence CK; Adam HJ; Idowu T; Domalaon R; Schweizer F; Zhanel MA; Lagacé-Wiens PRS; Walkty AJ; Noreddin A; Lynch Iii JP; Karlowsky JA
    Drugs; 2019 Feb; 79(3):271-289. PubMed ID: 30712199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of carbapenemases, extended spectrum β-lactamases, quinolone resistance and aminoglycoside resistance determinants in carbapenem-non-susceptible Escherichia coli from a teaching hospital in Chongqing, Southwest China.
    Zhang C; Xu X; Pu S; Huang S; Sun J; Yang S; Zhang L
    Infect Genet Evol; 2014 Oct; 27():271-6. PubMed ID: 25107431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of β-Lactamase-Producing Pathogens.
    Bush K; Bradford PA
    Clin Microbiol Rev; 2020 Mar; 33(2):. PubMed ID: 32102899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of carbapenemases, extended spectrum β-lactamases and molecular epidemiology of carbapenem-non-susceptible Enterobacter cloacae in a Chinese hospital in Chongqing.
    Dai W; Sun S; Yang P; Huang S; Zhang X; Zhang L
    Infect Genet Evol; 2013 Mar; 14():1-7. PubMed ID: 23220359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Infectious diseases caused by carbapenemase-producing Enterobacteriaceae--a particular challenge for antibacterial therapy].
    Stock I
    Med Monatsschr Pharm; 2014 May; 37(5):162-72; quiz 173-4. PubMed ID: 24908928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Beta-lactamases and their role in resistance. PART 2: beta-lactamases in 21st century].
    Bedenić B
    Lijec Vjesn; 2005; 127(1-2):12-21. PubMed ID: 16145868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis for carbapenem-hydrolyzing mechanisms of carbapenemases conferring antibiotic resistance.
    Jeon JH; Lee JH; Lee JJ; Park KS; Karim AM; Lee CR; Jeong BC; Lee SH
    Int J Mol Sci; 2015 Apr; 16(5):9654-92. PubMed ID: 25938965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of BAL30072 alone or combined with β-lactamase inhibitors or with meropenem against carbapenem-resistant Enterobacteriaceae and non-fermenters.
    Mushtaq S; Woodford N; Hope R; Adkin R; Livermore DM
    J Antimicrob Chemother; 2013 Jul; 68(7):1601-8. PubMed ID: 23449829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbapenemases in Enterobacteriaceae: types and molecular epidemiology.
    Martínez-Martínez L; González-López JJ
    Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():4-9. PubMed ID: 25542046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual-tubed multiplex-PCR for molecular characterization of carbapenemases isolated among Acinetobacter spp. and Pseudomonas spp.
    Kazi M; Nikam C; Shetty A; Rodrigues C
    J Appl Microbiol; 2015 May; 118(5):1096-102. PubMed ID: 25647446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbapenemases: Partners in crime.
    Bush K
    J Glob Antimicrob Resist; 2013 Mar; 1(1):7-16. PubMed ID: 27873609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular epidemiology of extended-spectrum β-lactamase-, AmpC β-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11.
    Denisuik AJ; Lagacé-Wiens PR; Pitout JD; Mulvey MR; Simner PJ; Tailor F; Karlowsky JA; Hoban DJ; Adam HJ; Zhanel GG;
    J Antimicrob Chemother; 2013 May; 68 Suppl 1():i57-65. PubMed ID: 23587779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution and epidemiology of extended-spectrum beta-lactamases (ESBLs) and ESBL-producing microorganisms.
    Gniadkowski M
    Clin Microbiol Infect; 2001 Nov; 7(11):597-608. PubMed ID: 11737084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New definitions of extended-spectrum β-lactamase conferring worldwide emerging antibiotic resistance.
    Lee JH; Bae IK; Lee SH
    Med Res Rev; 2012 Jan; 32(1):216-32. PubMed ID: 20577973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of the β-Lactamase Inhibitor LN-1-255 against Carbapenem-Hydrolyzing Class D β-Lactamases from Acinetobacter baumannii.
    Vázquez-Ucha JC; Maneiro M; Martínez-Guitián M; Buynak J; Bethel CR; Bonomo RA; Bou G; Poza M; González-Bello C; Beceiro A
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens.
    Pfeifer Y; Cullik A; Witte W
    Int J Med Microbiol; 2010 Aug; 300(6):371-9. PubMed ID: 20537585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Porin alterations present in non-carbapenemase-producing Enterobacteriaceae with high and intermediate levels of carbapenem resistance in Chile.
    Wozniak A; Villagra NA; Undabarrena A; Gallardo N; Keller N; Moraga M; Román JC; Mora GC; García P
    J Med Microbiol; 2012 Sep; 61(Pt 9):1270-1279. PubMed ID: 22700549
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.